Search All Tech Briefings

Search technology briefings produced by NIHR Innovation Observatory. These are short reports on new or repurposed medicines that we have already sent to our stakeholders. Only those technologies (medicines) that are within the scope of our stakeholders will have a technology briefing available. Search our technology briefings by intervention (drug or device), specific indication (disease or condition), or general therapeutic area.

| 81 Results

Clear All Filters

Title	Intervention	Indication	Therapeutic Area	Year	Actions
Brentuximab vedotin with cyclophosphamide, prednisone and doxorubicin for treating peripheral Tcell lymphoma	Brentuximab vedotin (Adcetris; SGN-35) , Cyclophosphamide (Procytox; cyclophosphamide monohydrate) , Doxorubicin (Livatag; BA-003; Caelyx; Sarcodoxome; SP-1049C; Resmycin; JNS002; doxorubicin hydrochloride) , Prednisone (Decadron; Lodotra)	Peripheral T-cell lymphoma (PTCL)	Haematological Cancer and Lymphomas	2024	View \| Download
Budesonide-glycopyrronium-formoterol fumarate for the treatment of severe and inadequately controlled asthma	Budesonide-glycopyrronium-formoterol fumarate	Asthma	Respiratory System	2024	View \| Download
Camlipixant for treating refractory or unexplained chronic cough	Camlipixant (NEO-5937; BLU-5937)	Chronic cough	Respiratory System	2024	View \| Download
Capivasertib with abiraterone acetate for treating metastatic PTEN deficient hormone-sensitive prostate cancer	Abiraterone acetate (Zytiga; Yonsa) , Capivasertib	Prostate cancer	Male Reproductive Cancer	2024	View \| Download
Cefepime-enmetazobactam for treating hospital-acquired pneumonia including ventilator-associated pneumonia	Exblifep (Cefepime;Enmetazobactam)	Hospital-acquired pneumonia , Ventilator-associated pneumonia	Infectious Disease , Respiratory System	2024	View \| Download
Darolutamide with androgen deprivation therapy for metastatic hormone sensitive prostate cancer	Darolutamide (ODM-201; BAY-1841788; Nubeqa)	Prostate cancer	Male Reproductive Cancer	2024	View \| Download
Datopotamab deruxtecan for previously untreated locally recurrent inoperable or metastatic triple-negative breast cancer	Datopotamab deruxtecan (DS-1062)	Breast cancer	Breast Cancer	2024	View \| Download
Depemokimab as adjunctive therapy for severe asthma with an eosinophilic phenotype in patients aged 12 years and older	Depemokimab	Asthma	Respiratory System	2024	View \| Download
Depemokimab for treating chronic rhinosinusitis withnasal polyps	Depemokimab	Nasal polyps , Rhinosinusitis	Ear Nose and Throat (ENT)	2024	View \| Download
Diclofenac-clotrimazole for treating recurrent vulvovaginal candidiasis	Diclofenac-clotrimazole	Vulvovaginal candidiasis	Gynaecology and Obstetrics , Infectious Disease	2024	View \| Download